Anna Moore

Insider Reports History

Location
Boston, MA
Signature
/s/ Thomas A. Fitzgerald, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anna Moore:

Company Role Class Num Shares Value Price $ Report Date Ownership
Transcode Therapeutics, Inc. 10%+ Owner Common Stock 1,552,785 $791,920 $0.5100 08 Jul 2021 Direct

Insider Reports Filed by Anna Moore

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAZ Transcode Therapeutics, Inc. 08 Jul 2021 0 $0 3 10%+ Owner 08 Jul 2021, 21:52